Correlation Between Covalon Technologies and NervGen Pharma

Can any of the company-specific risk be diversified away by investing in both Covalon Technologies and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Covalon Technologies and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Covalon Technologies and NervGen Pharma Corp, you can compare the effects of market volatilities on Covalon Technologies and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Covalon Technologies with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Covalon Technologies and NervGen Pharma.

Diversification Opportunities for Covalon Technologies and NervGen Pharma

0.6

Correlation Coefficient

Covalon Technologies  NervGen Pharma

Poor diversification

The 3 months correlation between Covalon and NervGen is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Covalon Technologies and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and Covalon Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Covalon Technologies are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of Covalon Technologies i.e., Covalon Technologies and NervGen Pharma go up and down completely randomly.

Pair Corralation between Covalon Technologies and NervGen Pharma

Assuming the 90 days horizon Covalon Technologies is expected to generate 1.4 times more return on investment than NervGen Pharma. However, Covalon Technologies is 1.4 times more volatile than NervGen Pharma Corp. It trades about -0.03 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about -0.2 per unit of risk. If you would invest  131.00  in Covalon Technologies on February 19, 2024 and sell it today you would lose (22.00) from holding Covalon Technologies or give up 16.79% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Covalon Technologies  vs.  NervGen Pharma Corp

Covalon Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Covalon Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

NervGen Pharma Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NervGen Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in June 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Covalon Technologies and NervGen Pharma

The main advantage of trading using opposite Covalon Technologies and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Covalon Technologies position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.

The idea behind Covalon Technologies and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..